 |
|
 Home |
 |
| Overview |
|
| Videos |
|
| Background |
|
| The Science |
|
| Contact Us |
|
| Replikins Press |
|
 |
|
|
The Science Advance Warning of the SARS Epidemic: Increase in Replikin Count™ peptide quantities in Spike and Nucleocapsid Coronavirus Proteins Preceded the SARS Coronavirus Epidemic of 2003 - Since the SARS coronavirus first appeared in 2003, it had no apparent history, unlike the influenza strains illustrated in Figures 1 and 2. However, Replikin analysis of the entire coronavirus group, of which SARS is a member, over the years in both humans and animals was surprisingly instructive. All 4,418 individual coronavirus protein sequences on Pubmed were analyzed with the FluForecast™ product.  1 2 3 4 5 |
| Recent Press | |
Boston, November 27, 2009 - Biotech firm Replikins Ltd., which has analyzed the H1N1 virus' genomic data from the 1918 pandemic through the prediction, outbreak, and progress of the current H1N1 pandemic, today issued its latest biochemical analysis of the virus... |
|
| New Non-Biological Synthetic Replikins™ Vaccines Shown to Be Effective and Fast; WorldVaccines™, Ltd. Formed for Testing and Distribution Old Biological Vaccines for Emergent Diseases - Too Little, Too Late
Boston, October 19, 2009 - There is increasing evidence that, with best intent, current biological technology cannot supply the world's six billion humans, and animal populations, with vaccines against emerging diseases at a rate that can contend with a disease's rapid appearance and change... |
|
Copyright © 2010 Replikins Ltd. All rights reserved.